Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction

279Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND - Renal function is an important risk marker for morbidity and mortality in chronic heart failure (CHF) and is often estimated with the use of creatinine-based formulas. However, these formulas have never been validated in a wide range of CHF patients. We validated 3 commonly used formulas estimating glomerular filtration rate (GFR) with true GFR in CHF patients. Furthermore, we compared the prognostic value of these formulas for cardiovascular outcome with that of true GFR during 12 months of follow-up. METHODS AND RESULTS - In 110 CHF patients (age, 57±11.7 years; left ventricular ejection fraction, 0.27±0.09; NYHA class, 2.5±0.9), we measured I-iothalamate clearance. Cockcroft-Gault (GFRcg), Modification of Diet in Renal Disease (MDRD), and simplified MDRD (sMDRD) equations were used as creatinine-based renal function estimations. Furthermore, 24-hour creatinine clearance (CrCl) was determined. CrCl and GFRcg were the most accurate. MDRD was most precise formula, although it was also highly biased. All formulas overestimated in the lower ranges and underestimated in the upper ranges of the GFR corrected for body surface area. The predictive performance of the formulas was best in severe CHF (NYHA classes III and IV). The prognostic value of CrCl and MDRD for cardiovascular outcome was comparable to that of GFR, the sMDRD was slightly less, and the GFRcg had a significantly worse prognostic value. CONCLUSIONS - In the more severe ranges of CHF, creatinine-based formulas and CrCl corrected for body surface area appeared to be more precise and accurate in estimating true GFR corrected for body surface area. The MDRD formula is the most precise and has a good prognostic value, whereas the sMDRD is slightly less accurate but uses fewer parameters, which makes this formula a practical alternative in clinical practice. © 2006 American Heart Association, Inc.

Cite

CITATION STYLE

APA

Smilde, T. D. J., Van Veldhuisen, D. J., Navis, G., Voors, A. A., & Hillege, H. L. (2006). Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation, 114(15), 1572–1580. https://doi.org/10.1161/CIRCULATIONAHA.105.610642

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free